Richard I. Fisher
Temple University
H-index: 121
North America-United States
Top articles of Richard I. Fisher
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome | Alzheimer's & Dementia | Hampus Hillerstrom Richard Fisher Matthew P Janicki Brian Chicoine Bradley T Christian | 2024/3/13 |
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma | Blood Advances | James N Gerson Elizabeth Handorf Diego Villa Alina S Gerrie Parv Chapani | 2023/12/26 |
Impact of Psychological Distress on Immune Phenotype in CLL/SLL Patients Managed By Active Observation | Blood | Carolyn Y Fang Jakub Svoboda Adam D Cohen Henry C Fung Richard I Fisher | 2023/11/28 |
OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, AND CAR T CELL THERAPY IN TP53 ALTERED MANTLE CELL LYMPHOMA: A MULTI‐INSTITUTION RETROSPECTIVE ANALYSIS | Hematological Oncology | M Messmer A Stack M Deng E Handorf N Kapoor | 2023/6 |
Adverse events reported by patients with cancer after administration of a 2-dose mRNA COVID-19 vaccine | Journal of the National Comprehensive Cancer Network | Rebecca M Shulman David S Weinberg Eric A Ross Karen Ruth Glenn F Rall | 2022/2/1 |
Improving goal concordant care among 10 leading academic US cancer hospitals: a collaboration of the alliance of dedicated cancer centers | The Oncologist | Kristen K McNiff Michael A Caligiuri Nancy E Davidson William Farrar Richard I Fisher | 2021/7/1 |
Survival predictor for diffuse large B cell lymphoma | 2021/6/8 | ||
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … | The Lancet | Merryn Voysey Sue Ann Costa Clemens Shabir A Madhi Lily Y Weckx Pedro M Folegatti | 2021/3/6 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK | The Lancet | Merryn Voysey Sue Ann Costa Clemens Shabir A Madhi Lily Y Weckx Pedro M Folegatti | 2020/12/8 |
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial | The Lancet | Maheshi N Ramasamy Angela M Minassian Katie J Ewer Amy L Flaxman Pedro M Folegatti | 2020/12/19 |
A phase I trial assessing the feasibility of romidepsin combined with brentuximab vedotin for patients requiring systemic therapy for cutaneous T-cell lymphoma | Blood | Stefan K Barta Tatyana A Feldman Jennifer A DeSimone Ellen Kim Karthik Devajaran | 2022/11/15 |
Positron emission tomography–directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of Intergroup National Clinical Trials Network Study S1001 | Journal of Clinical Oncology | Daniel O Persky Hongli Li Deborah M Stephens Steven I Park Nancy L Bartlett | 2020/9/9 |
Methods for identifying, diagnosing, and predicting survival of lymphomas | 2012/3/6 | ||
A war on two fronts: cancer care in the time of COVID-19 | Alexander Kutikov David S Weinberg Martin J Edelman Eric M Horwitz Robert G Uzzo | 2020/6/2 |
